Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Impact of oxygenation status and patient age on DNA content in cancers of the uterine cervix.

Mayer A, Höckel M, Thews O, Schlenger K, Vaupel P.

Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):929-36.

PMID:
12829127
2.

Association between host tissue vascularity and the prognostically relevant tumor vascularity in human cervical cancer.

Höckel S, Schlenger K, Vaupel P, Höckel M.

Int J Oncol. 2001 Oct;19(4):827-32.

PMID:
11562762
3.

Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblasts.

Pilch H, Schlenger K, Steiner E, Brockerhoff P, Knapstein P, Vaupel P.

Int J Gynecol Cancer. 2001 Mar-Apr;11(2):137-42.

PMID:
11328412
4.

[Angiogenesis in cervical cancer].

Pilch H, Schäffer U, Schlenger K, Hawighorst H, Tanner B, Bahlmann F, Höckel M, Kanpstein PG.

Gynecol Obstet Fertil. 2000 Jan;28(1):29-37. French.

PMID:
10774115
5.

Hypoxic cervical cancers with low apoptotic index are highly aggressive.

Höckel M, Schlenger K, Höckel S, Vaupel P.

Cancer Res. 1999 Sep 15;59(18):4525-8.

6.

Expression of tenascin in human cervical cancer--association of tenascin expression with clinicopathological parameters.

Pilch H, Schäffer U, Schlenger K, Lautz A, Tanner B, Höckel M, Knapstein PG.

Gynecol Oncol. 1999 Jun;73(3):415-21.

PMID:
10366470
7.

Tumor hypoxia in pelvic recurrences of cervical cancer.

Höckel M, Schlenger K, Höckel S, Aral B, Schäffer U, Vaupel P.

Int J Cancer. 1998 Aug 21;79(4):365-9.

8.

Quantitative angiogenesis assays: progress and problems.

Jain RK, Schlenger K, Höckel M, Yuan F.

Nat Med. 1997 Nov;3(11):1203-8. Review. No abstract available.

PMID:
9359693
9.
10.

Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix.

Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P.

Cancer Res. 1996 Oct 1;56(19):4509-15.

11.

Hypoxia and Radiation Response in Human Tumors.

Höckel M, Schlenger K, Mitze M, Schäffer U, Vaupel P.

Semin Radiat Oncol. 1996 Jan;6(1):3-9.

PMID:
10717157
12.

Tumor vascularity--a novel prognostic factor in advanced cervical carcinoma.

Schlenger K, Höckel M, Mitze M, Schäffer U, Weikel W, Knapstein PG, Lambert A.

Gynecol Oncol. 1995 Oct;59(1):57-66.

PMID:
7557616
13.

How to improve the uterotomy healing. I. Effects of fibrin and tumor necrosis factor-alpha in the rat uterotomy model.

Schlenger K, Höckel M, Schwab R, Frischmann-Berger R, Vaupel P.

J Surg Res. 1994 Mar;56(3):235-41.

PMID:
8145540
14.

Intratumoral pO2 histography as predictive assay in advanced cancer of the uterine cervix.

Höckel M, Knoop C, Schlenger K, Vorndran B, Knapstein PG, Vaupel P.

Adv Exp Med Biol. 1994;345:445-50. No abstract available.

PMID:
8079741
15.

Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix.

Höckel M, Vorndran B, Schlenger K, Baussmann E, Knapstein PG.

Gynecol Oncol. 1993 Nov;51(2):141-9.

PMID:
8276286
16.

Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone.

Okunieff P, Hoeckel M, Dunphy EP, Schlenger K, Knoop C, Vaupel P.

Int J Radiat Oncol Biol Phys. 1993 Jul 15;26(4):631-6.

PMID:
8330993
17.

Therapeutic angiogenesis.

Höckel M, Schlenger K, Doctrow S, Kissel T, Vaupel P.

Arch Surg. 1993 Apr;128(4):423-9. Review.

PMID:
7681277
18.

Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.

Höckel M, Knoop C, Schlenger K, Vorndran B, Baussmann E, Mitze M, Knapstein PG, Vaupel P.

Radiother Oncol. 1993 Jan;26(1):45-50.

PMID:
8438086
19.

Blood flow and tissue oxygenation of human tumors: an update.

Vaupel P, Schlenger K, Hoeckel M.

Adv Exp Med Biol. 1992;317:139-51. Review. No abstract available.

PMID:
1288121
20.

Oxygenation of mammary tumors: from isotransplanted rodent tumors to primary malignancies in patients.

Vaupel P, Schlenger KH, Hoeckel M, Okunieff P.

Adv Exp Med Biol. 1992;316:361-71.

PMID:
1288097
21.

Oxygenation of carcinomas of the uterine cervix: evaluation by computerized O2 tension measurements.

Höckel M, Schlenger K, Knoop C, Vaupel P.

Cancer Res. 1991 Nov 15;51(22):6098-102.

22.
23.

Pathophysiological approaches to identifying tumor hypoxia in patients.

Mueller-Klieser W, Schlenger KH, Walenta S, Gross M, Karbach U, Hoeckel M, Vaupel P.

Radiother Oncol. 1991;20 Suppl 1:21-8.

PMID:
2020765
24.

Tumor blood flow: the principal modulator of oxidative and glycolytic metabolism, and of the metabolic micromilieu of human tumor xenografts in vivo.

Kallinowski F, Schlenger KH, Kloes M, Stohrer M, Vaupel P.

Int J Cancer. 1989 Aug 15;44(2):266-72.

PMID:
2759732
25.

Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts.

Kallinowski F, Schlenger KH, Runkel S, Kloes M, Stohrer M, Okunieff P, Vaupel P.

Cancer Res. 1989 Jul 15;49(14):3759-64.

26.

Glucose, lactate, and ketone body utilization by human gynecological tumors xenografted into rnu/rnu-rats.

Kallinowski F, Schlenger K, Runkel S, Vaupel P, Baessler KH, Fortmeyer HP.

Strahlenther Onkol. 1989 Jul;165(7):507-8. No abstract available.

PMID:
2749484
27.

Blood flow and oxygen consumption rates of human gynecological tumors xenografted into rnu/rnu-rats.

Vaupel P, Kallinowski F, Runkel S, Schlenger K, Fortmeyer HP.

Strahlenther Onkol. 1989 Jul;165(7):502. No abstract available.

PMID:
2749480

Supplemental Content

Loading ...
Support Center